Net sales also increased from the third quarter of 2012, up 2.8 percent to $4.03 billion. However, overall net earnings dropped slightly over the past nine months from the same period in 2012. Nine-month-end net earnings reached nearly $2.5 billion, down 4.9 percent from 2012’s $2.6 billion.
Reported revenue for spine devices also dipped in the third quarter to $753 million, down nearly 4 percent from $784 million in the third quarter 2012.
More Articles on Devices:
OsteoFab Orthopedic Device Receives FDA Clearance
Dr. Richard Kube Performs First Coflex Interlaminar Implant in Illinois
Sports Medicine Device Sales Increase Arthrocare’s 4Q Revenue by 4.9%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.